Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Other Operating Expenses (2020 - 2024)

Historic Other Operating Expenses for Rani Therapeutics Holdings (RANI) over the last 2 years, with Q4 2024 value amounting to $3.7 million.

  • Rani Therapeutics Holdings' Other Operating Expenses changed N/A to $3.7 million in Q4 2024 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Rani Therapeutics Holdings' Other Operating Expenses stood at $3.7 million.
  • Rani Therapeutics Holdings' 5-year Other Operating Expenses high stood at $3.7 million for Q4 2024, and its period low was -$34.0 million during Q4 2020.